Selecting Compound for Long Acting Injections and Available Technologies

3/10/2020 11:35 - 12:10

  • Why is long acting injectable formulation relevant from a clinical perspective?
  • Pharmacokinetic and physical chemical considerations when initiating a formulation program for a long acting injectible product
  • Formulation strategies available for long acting injecting release – including some examples

Please note that this will be a remote presentation

Rene Holm, Head and Scientific Director, Liquids & Parenterals, Janssen